Trial intelligence / Profile preview

Roxadustat in peritoneal dialysis patients with renal anemia

ChiCTR2000035054Phase 4Recruiting

Sponsor
The 2nd Affiliated Hospital of Harbin Medical University
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of roxadustat in Uraemic Anaemia (2 arms), sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoint: hemoglobin. Started Jul 2020; status: recruiting.

02

Drugs

roxadustat
03

Conditions

Uraemic Anaemia

Beyond the preview

Go deeper on ChiCTR2000035054.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000035054.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call